Aug 20, 2019

Endo and Allergan discussing opioid settlement to avoid trial

Photo: Liz O. Baylen/Los Angeles Times/Getty Images

Two drug companies — Endo and Allergan — are in discussions about a settlement that would allow them to avoid participating in a massive opioids trial set to occur this fall, the Wall Street Journal reports. Endo is working on a $10 million deal, while Allergan is negotiating a $5 million deal that may not completely remove it from the trial.

Why it matters: These 2 companies are relatively minor players in the trial, especially compared to drugmakers like Purdue Pharma and Johnson and Johnson. But this would still be a significant development, especially if other drug companies end up following Endo and Allergan's lead to avoid going to trial.

Go deeper: A proposal to bring all local governments into opioids settlement

Go deeper

Podcast: Johnson & Johnson's landmark opioids verdict

Dan talks with Axios health-care business reporter Bob Herman how Johnson & Johnson became the first drug maker to be held liable in an opioids case and how it could set the stage for the first federal opioids trial this fall in Ohio.

Go deeper: Why Johnson & Johnson's opioids verdict is both big and small

Keep ReadingArrowAug 27, 2019

Drug companies in massive opioids lawsuit call for judge's removal over bias

Members of P.A.I.N. (Prescription Addiction Intervention Now) and Truth Pharm protest on Sept. 12 outside Purdue Pharma headquarters. Photo: Erik McGregor/LightRocket via Getty Images

Drug companies in a massive legal battle over their alleged roles in fueling the opioid epidemic are calling for the federal judge in their case to be removed over the appearance of bias, the Washington Post reports.

Where it stands: These drug companies, which face thousands of lawsuits from cities and other communities, are scheduled for trial Oct. 21. The drug companies are "questioning" U.S. District Judge Dan Polster's "impartiality because he has consistently urged both sides to settle the case," per the Post.

Go deeperArrowSep 14, 2019

Purdue Pharma reaches tentative opioids settlement

Photo: Drew Angerer/Getty Images

Purdue Pharma has tentatively reached the first "global" settlement in the nationwide opioids lawsuit, the New York Times and AP report. The plaintiffs later confirmed this to Axios.

The big picture: The deal would reportedly result in the maker of OxyContin entering bankruptcy and the Sackler family owners paying $3 billion over 7 years, among other terms. Some states still aren't on board with the proposal and may pursue Purdue and the Sacklers further, NYT reports. But the first major deal appears imminent ahead of the scheduled October trial.